Intellistake provides scientific update on proposed NanoAi acquisition

• Intellistake is pursuing a proposed acquisition of NanoAi Technologies under a definitive agreement dated Aug. 3, 2026.
• Closing is targeted within 60 days, subject to due diligence, an audit of NanoAi financial statements, CSE clearance, and a $2 million minimum cash balance.
• The buyer highlighted peer-reviewed validation of NanoAi’s core nanotechnology sensing process, published in Nature Portfolio’s Scientific Reports in March 2022.
• The study tested a handheld breath analyzer on 84 subjects, reporting 100% sensitivity, 87.04% specificity, and 91.36% accuracy.
• NanoAi also cited a royalty-free development license with Gentex to integrate sensors into the Ops-Core RAILINK helmet platform.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Intellistake Technologies Corp. published the original content used to generate this news brief on August 11, 2026, and is solely responsible for the information contained therein.